The company aims to revolutionize the ability of medical practitioners to detect the presence of colorectal cancer at the earliest possible stage, improving the survival rate for the third most common cancer in the world.
Price: EUR 2,000,000
Unique system with a great potential. Top scientists and hospital institutions are behind this project.
Only for REGISTERED USERS. If you are a REGISTERED USER please login. If you are not a REGISTERED USER and want to receive a more detailed business summary of this listing, please register.
